Chang Gung Memorial Hospital Cgmh - Kaohsiung Branch

Kaohsiung City 833401

0 studies enrolling now · 5 studies all time

What they study most

Advanced Cholangiocarcinoma, Cholangiocarcinoma, Colorectal Cancer (CRC), Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, FGFR2 Gene Rearrangements, Head and Neck Squamous Cell Carcinoma (HNSCC), Malignant Solid Tumor, Melanoma, Metastatic Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC)

Studies at this site

• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors — Running, not enrolling
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early
• A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures — Completed